Nanovery
DNA nanorobot assays for biotech and life sciences researchers quantifying RNA therapeutics and nucleic acid biomarkers
Highlights
- New on EvolcAdded 2026-11-07
About Nanovery
Nanovery develops DNA nanorobotic sensors and assays for detecting and quantifying nucleic acids in biological samples. Its products include bioanalysis assays for antisense oligonucleotides and siRNA, custom assay development, and microRNA biomarker testing.
The company works with researchers and organizations in biotechnology, drug development, and life sciences. Assays use fluorescent signals measured with a standard plate reader.
NANOVERY LIMITED was founded in 2018 and is headquartered in Newcastle Upon Tyne, United Kingdom. Nanovery also describes applications in drug safety, RNA diagnostics, gene therapy, cell therapy, infectious diseases, and vaccines.
Product: DNA nanorobot-based assays for nucleic acid detection and quantification, including ASO, siRNA, custom assays, and microRNA biomarker testing.
Jobs at Nanovery
Leadership
- Jurek Kozyra · Founder CEOSource: company website
- Roma Galloway · Co-founder COOSource: company website
More biotech & pharma companies
Neobe Therapeutics
Engineers live bacterial therapeutics to help immunotherapies reach solid tumours in patients with immune-excluded cancersNew on EvolcNeoceuticals
Paediatric and specialist oral medicines and nutritional products for healthcare markets in the UK and overseasNew on EvolcNeon Healthcare
Supplies prescription medicines to hospitals, pharmacies and other healthcare providersNew on EvolcNeovac
Develops lipid platforms and formulation kits for researchers advancing RNA therapeuticsNew on EvolcNeurolieve Biosciences
Developing a non-opioid biologic for patients with neuropathic pain, designed to relieve pain and support nerve regenerationYoung companyNew on EvolcNexus Bioquest
Immunology CRO running custom assays and pre-clinical drug discovery studies for pharma and biotech teamsYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- PrismicHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
Hosting
- VercelHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-vercel-id
- Response headerx-vercel-id
- Response headerx-vercel-id
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.